ArticleBrain structure & function2026
Characterizing functional connectivity gradients for the hippocampus-amygdala complex in healthy and psychiatric cohorts.
Article in Brain structure & function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hippocampus and amygdala play essential roles in human cognition and emotion, through their extensive connectivity with other brain regions and close interaction between them. Uncovering the functional organization of the hippocampus-amygdala complex and its relationship with neurotransmitter distribution can enhance our understanding of their biological functionality, and provide a basis for further exploration of the clinical relevance. An emerging functional connectivity analysis method termed connectopic mapping, may offer a novel approach to characterize this functional organization. In this study, we applied connectopic mapping to the hippocampus-amygdala complex, testing its utility with resting-state functional magnetic resonance imaging (fMRI) scans of two independent datasets: one comprising healthy individuals (N = 410) and another comprising a psychiatric cohort (N = 367). The spatial organization of derived gradient maps was compared to 18 positron emission tomography (PET) or single photon emission computed tomography (SPECT) scan templates for different neurotransmitter systems. Individual gradient-neurotransmitter similarity indices were correlated with mental health outcomes. Our analyses identified six distinct gradient maps in both datasets. The third-order gradients showed stable similarity with 5-HT1A receptor maps across various resting-state scans. Similarities were also observed between gradient maps and the distribution patterns of neurotransmitters within the dopaminergic system. Individual gradient-to-5-HT1A similarity was positively correlated with depressive severity and anxiety sensitivity, highlighting the psychopathological relevance. These findings demonstrate that across the psychiatric continuum, connectopic mapping is a powerful tool for exploring the relationship between functional connectivity organization and neurotransmitter distribution, showing potential as a comprehensive transdiagnostic biomarker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.